Biofrontera- Warrants (27/10/2026) Profit Margin

As of the most recent data (June 2026), BFRIW shows a profit margin of -13.78%. That compares with -42.35% in the prior-year period — up 67.4% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BFRIW's profit margin is now -13.78% (was -42.35%) — a 67.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biofrontera- Warrants (27/10/2026) is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Biofrontera- Warrants (27/10/2026) is at -13.78%, which is lower that average. That is roughly 164.6% below the sector mean. Use the comparison chart on this page to see how BFRIW stacks up against individual peers as well.

That compares with -42.35% in the prior-year period — up 67.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biofrontera- Warrants (27/10/2026) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Biofrontera- Warrants (27/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -13.78%) with ownership activity and broader fundamentals.